Thus, our results suggested that attenuating TauT‐mediated taurine export/import might be a promising adjuvant therapeutic strategy to restore the sensitivity to ferroptosis during PCa treatment. The gene discussed is SLC6A6; the disease is posterior cortical atrophy.